GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

U-Neuron Biomedical 6973.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

56.70

+7.18%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2024

Revenue

TWD 46.2m

FY2021FY2024

Net income

−TWD 60.0m

FY2021FY2024

Free cash flow

−TWD 98.8m

FY2021FY2024

Shareholders' equity

TWD 811.4m

FY2021FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021
RevenueTWD 46.2mTWD 27.0mTWD 26.8mTWD 28.4m
Gross profitTWD 37.9mTWD 21.6mTWD 21.6mTWD 23.9m
Research and developmentTWD 77.4mTWD 76.2mTWD 45.6mTWD 25.4m
Operating income−TWD 69.0m−TWD 90.3m−TWD 43.7m−TWD 15.1m
Net income−TWD 60.0m−TWD 84.9m−TWD 43.2m−TWD 11.3m
Diluted earnings per share-1.76-3.18-1.46-0.38

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021
Total assetsTWD 846.7mTWD 523.2mTWD 186.3mTWD 211.4m
Cash and short-term investmentsTWD 748.8mTWD 476.0mTWD 163.0mTWD 196.5m
Total liabilitiesTWD 35.3mTWD 31.2mTWD 23.0mTWD 15.9m
DebtTWD 4.9mTWD 9.7mTWD 4.4m—
Shareholders' equityTWD 811.4mTWD 492.0mTWD 163.3mTWD 195.4m
Shares outstanding34m27m30m30m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021
Cash from operations−TWD 53.9m−TWD 53.2m−TWD 36.4m−TWD 653,000
Capital spending−TWD 44.9m−TWD 2.4m−TWD 3.4m−TWD 1.9m
Free cash flow−TWD 98.8m−TWD 55.6m−TWD 39.7m−TWD 2.5m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022
RevenueTWD 40.1mTWD 25.4mTWD 20.8mTWD 15.0mTWD 12.0mTWD 11.5mTWD 15.2m
Gross profitTWD 26.4mTWD 22.2mTWD 15.7mTWD 11.8mTWD 9.8mTWD 9.8mTWD 11.7m
Operating income−TWD 28.3m−TWD 33.2m−TWD 35.8m−TWD 32.6m−TWD 57.8m−TWD 25.9m−TWD 17.8m
Net income−TWD 23.5m−TWD 27.6m−TWD 32.3m−TWD 28.8m−TWD 56.1m−TWD 26.2m−TWD 17.0m
Diluted earnings per share-0.60-0.76-1.02-0.90-2.80-0.89-0.58
Cash from operations−TWD 33.0m−TWD 17.0m−TWD 35.0m−TWD 18.0m−TWD 34.0m−TWD 18.0m−TWD 18.0m
Capital spending−TWD 29.0m−TWD 7.0m−TWD 37.0m−TWD 1.0m—−TWD 1.0m−TWD 2.0m
Free cash flow−TWD 62.0m−TWD 24.0m−TWD 72.0m−TWD 19.0m—−TWD 19.0m−TWD 20.0m
Total assetsTWD 783.5mTWD 846.7mTWD 490.6mTWD 523.2mTWD 539.5mTWD 186.3mTWD 200.2m
Cash and short-term investmentsTWD 640.0mTWD 748.8mTWD 400.1mTWD 476.0mTWD 515.1mTWD 163.0mTWD 173.7m
DebtTWD 13.1m—TWD 2.4mTWD 4.9m——TWD 2.2m
Shareholders' equityTWD 744.9mTWD 811.4mTWD 460.9mTWD 492.0mTWD 522.3mTWD 163.3mTWD 178.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue17.6%——
Operating income66.0%——
Net income74.6%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin81.2%81.7%——

Valuation history

At each fiscal year end

FY2024FY2023
Price to earnings-23.7-18.9
Price to sales30.859.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.